Follow
Gregory J. Gores
Gregory J. Gores
Verified email at mayo.edu
Title
Cited by
Cited by
Year
A global view of hepatocellular carcinoma: trends, risk, prevention and management
JD Yang, P Hainaut, GJ Gores, A Amadou, A Plymoth, LR Roberts
Nature reviews Gastroenterology & hepatology 16 (10), 589-604, 2019
30442019
Staging
W Sanchez, GJ Gores
Hepatocellular Carcinoma, 102-111, 2009
27962009
Design and endpoints of clinical trials in hepatocellular carcinoma
JM Llovet, AM Di Bisceglie, J Bruix, BS Kramer, R Lencioni, AX Zhu, ...
Journal of the National Cancer Institute 100 (10), 698-711, 2008
20362008
Mechanisms of hepatotoxicity
H Jaeschke, GJ Gores, AI Cederbaum, JA Hinson, D Pessayre, ...
Toxicological sciences 65 (2), 166-176, 2002
17762002
Cholangiocarcinoma
N Razumilava, GJ Gores
The Lancet 383 (9935), 2168-2179, 2014
16642014
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
J Bridgewater, PR Galle, SA Khan, JM Llovet, JW Park, T Patel, TM Pawlik, ...
Journal of hepatology 60 (6), 1268-1289, 2014
15432014
Diagnosis and management of primary sclerosing cholangitis
R Chapman, J Fevery, A Kalloo, DM Nagorney, KM Boberg, B Shneider, ...
Hepatology 51 (2), 660-678, 2010
14682010
Hepatocellular carcinoma: clinical frontiers and perspectives
J Bruix, GJ Gores, V Mazzaferro
Gut 63 (5), 844-855, 2014
14662014
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
JM Banales, JJG Marin, A Lamarca, PM Rodrigues, SA Khan, LR Roberts, ...
Nature reviews Gastroenterology & hepatology 17 (9), 557-588, 2020
14472020
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis
AE Feldstein, A Canbay, P Angulo, M Taniai, LJ Burgart, KD Lindor, ...
Gastroenterology 125 (2), 437-443, 2003
12962003
Cholangiocarcinoma—evolving concepts and therapeutic strategies
S Rizvi, SA Khan, CL Hallemeier, RK Kelley, GJ Gores
Nature reviews Clinical oncology 15 (2), 95-111, 2018
12892018
Pathogenesis, diagnosis, and management of cholangiocarcinoma
S Rizvi, GJ Gores
Gastroenterology 145 (6), 1215-1229, 2013
12582013
Biliary tract cancers
PC De Groen, GJ Gores, NF LaRusso, LL Gunderson, DM Nagorney
New England Journal of Medicine 341 (18), 1368-1378, 1999
12031999
Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report
PA Clavien, M Lesurtel, PMM Bossuyt, GJ Gores, B Langer, A Perrier
The lancet oncology 13 (1), e11-e22, 2012
11382012
Free fatty acids promote hepatic lipotoxicity by stimulating TNF‐α expression via a lysosomal pathway
AE Feldstein, NW Werneburg, A Canbay, ME Guicciardi, SF Bronk, ...
Hepatology 40 (1), 185-194, 2004
11262004
mir-29 regulates Mcl-1 protein expression and apoptosis
JL Mott, S Kobayashi, SF Bronk, GJ Gores
Oncogene 26 (42), 6133-6140, 2007
10842007
Apoptosis and necrosis in the liver: a tale of two deaths?
H Malhi, GJ Gores, JJ Lemasters
Hepatology 43 (S1), S31-S44, 2006
9112006
Cathepsin B contributes to TNF-α–mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c
ME Guicciardi, J Deussing, H Miyoshi, SF Bronk, PA Svingen, C Peters, ...
The Journal of clinical investigation 106 (9), 1127-1137, 2000
8952000
Ursodeoxycholic Acid or Clofibrate in the Treatment of Non–Alcohol–Induced Steatohepatitis: A Pilot Study
J Laurin, KD Lindor, JS Crippin, A Gossard, GJ Gores, J Ludwig, J Rakela, ...
Hepatology 23 (6), 1464-1467, 1996
8951996
Life and death by death receptors
ME Guicciardi, GJ Gores
The FASEB Journal 23 (6), 1625, 2009
8662009
The system can't perform the operation now. Try again later.
Articles 1–20